
When researchers recently scrutinised some clinical trials for experimental medicines conducted by multinational pharmaceutical companies in India, they were troubled by a number of findings.
By Andrew Jack
Published: June 5 2009 22:12 | Last updated: June 5 2009 22:12

When researchers recently scrutinised some clinical trials for experimental medicines conducted by multinational pharmaceutical companies in India, they were troubled by a number of findings.